https://cbmr.ku.dk/research/research-groups/schwartz-group/news---schwartz-group/ List of news from the Schwartz Group at CBMR. en Mon, 18 May 2026 16:16:16 +0200 Mon, 18 May 2026 16:16:16 +0200 https://cbmr.ku.dk/news/2024/faces-of-cbmr-sofie-liljewall/ Sofie Liljewall is an industrial PhD Student at SOLID Therapeutics and CBMR. Sofie has a Master’s...<div class="item-image"><a href="https://cbmr.ku.dk/news/2024/faces-of-cbmr-sofie-liljewall/" alt="“Working in a small company where I get insights into everything is fantastic”" title="“Working in a small company where I get insights into everything is fantastic”"><img src="https://cbmr.ku.dk/news/2024/faces-of-cbmr-sofie-liljewall/Faces_of_CBMR_Sofie_Liljewall_11x6.jpg/" border="0" alt="" /></a></div> https://cbmr.ku.dk/news/2024/faces-of-cbmr-sofie-liljewall/ Tue, 04 Jun 2024 10:00:00 +0200 https://cbmr.ku.dk/news/2023/ucph-innovation-prize-2023/ A founding member of CBMR, Professor Thue W. Schwartz is a pioneering fundamental researcher and co-founder...<div class="item-image"><a href="https://cbmr.ku.dk/news/2023/ucph-innovation-prize-2023/" alt="Professor Thue W. Schwartz wins UCPH Innovation Prize 2023" title="Professor Thue W. Schwartz wins UCPH Innovation Prize 2023"><img src="https://cbmr.ku.dk/news/2023/images/1_thue_and_queen.jpeg/" border="0" alt="" /></a></div> https://cbmr.ku.dk/news/2023/ucph-innovation-prize-2023/ Mon, 13 Nov 2023 11:00:00 +0100 https://cbmr.ku.dk/news/2023/novo-nordisk-buys-cbmr-biotech-spinout-to-acquire-their-novel-approach-for-treating-obesity-and-type-2-diabetes/ Researchers from University of Copenhagen discovered a target that suppresses hunger, stimulates calorie...<div class="item-image"><a href="https://cbmr.ku.dk/news/2023/novo-nordisk-buys-cbmr-biotech-spinout-to-acquire-their-novel-approach-for-treating-obesity-and-type-2-diabetes/" alt="Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes" title="Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes"><img src="https://cbmr.ku.dk/images/CBMR_Foyer_1100x600.jpg/" border="0" alt="" /></a></div> https://cbmr.ku.dk/news/2023/novo-nordisk-buys-cbmr-biotech-spinout-to-acquire-their-novel-approach-for-treating-obesity-and-type-2-diabetes/ Wed, 30 Aug 2023 09:00:00 +0200 https://cbmr.ku.dk/news/2022/two-cbmr-group-leaders-join-the-bioinnovation-institutes-venture-lab-program/ Scientists at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) study metabolic...<div class="item-image"><a href="https://cbmr.ku.dk/news/2022/two-cbmr-group-leaders-join-the-bioinnovation-institutes-venture-lab-program/" alt="Two CBMR Group Leaders join the BioInnovation Institute’s Venture Lab program" title="Two CBMR Group Leaders join the BioInnovation Institute’s Venture Lab program"><img src="https://cbmr.ku.dk/news/2020/cbmr-scientists-win-innovation-funding-to-develop-new-anti-cancer-and-obesity-drugs/news20-12_bii_nnf_preseed_dsc02249_1100px.jpg/" border="0" alt="" /></a></div> https://cbmr.ku.dk/news/2022/two-cbmr-group-leaders-join-the-bioinnovation-institutes-venture-lab-program/ Tue, 15 Mar 2022 09:30:00 +0100 https://cbmr.ku.dk/news/2020/a-cellular-call-for-help-succinate-boosts-the-anti-inflammatory-power-of-white-blood-cells/ When succinate is released by cells in distress it activates nearby white blood cells, and surprisingly...<div class="item-image"><a href="https://cbmr.ku.dk/news/2020/a-cellular-call-for-help-succinate-boosts-the-anti-inflammatory-power-of-white-blood-cells/" alt="A Cellular Call for Help" title="A Cellular Call for Help"><img src="https://cbmr.ku.dk/news/2020/a-cellular-call-for-help-succinate-boosts-the-anti-inflammatory-power-of-white-blood-cells/Graphical_abstract3_1100x600.jpg/" border="0" alt="" /></a></div> https://cbmr.ku.dk/news/2020/a-cellular-call-for-help-succinate-boosts-the-anti-inflammatory-power-of-white-blood-cells/ Mon, 02 Aug 2021 11:30:00 +0200 https://cbmr.ku.dk/news/2020/cbmr-scientists-win-innovation-funding-to-develop-new-anti-cancer-and-obesity-drugs/ The BioInnovation Institute (BII) has awarded two grants worth DKK 3.5M each to CBMR to develop new drugs...<div class="item-image"><a href="https://cbmr.ku.dk/news/2020/cbmr-scientists-win-innovation-funding-to-develop-new-anti-cancer-and-obesity-drugs/" alt="CBMR scientists win innovation funding to develop new anti-cancer and obesity drugs" title="CBMR scientists win innovation funding to develop new anti-cancer and obesity drugs"><img src="https://cbmr.ku.dk/news/2020/cbmr-scientists-win-innovation-funding-to-develop-new-anti-cancer-and-obesity-drugs/news20-12_bii_nnf_preseed_dsc02249_1100px.jpg/" border="0" alt="" /></a></div> https://cbmr.ku.dk/news/2020/cbmr-scientists-win-innovation-funding-to-develop-new-anti-cancer-and-obesity-drugs/ Wed, 02 Dec 2020 12:30:00 +0100